Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival

Understanding how antibody responses to SARS-CoV-2 evolve during infection may provide important insight into therapeutic approaches and vaccination for COVID-19. Here we profile the antibody responses of 162 COVID-19 symptomatic patients in the COVID-BioB cohort followed longitudinally for up to ei...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nat Commun
Main Authors: Dispinseri, Stefania, Secchi, Massimiliano, Pirillo, Maria Franca, Tolazzi, Monica, Borghi, Martina, Brigatti, Cristina, De Angelis, Maria Laura, Baratella, Marco, Bazzigaluppi, Elena, Venturi, Giulietta, Sironi, Francesca, Canitano, Andrea, Marzinotto, Ilaria, Tresoldi, Cristina, Ciceri, Fabio, Piemonti, Lorenzo, Negri, Donatella, Cara, Andrea, Lampasona, Vito, Scarlatti, Gabriella
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8113594/
https://ncbi.nlm.nih.gov/pubmed/33976165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-021-22958-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados